TRUIST FINANCIAL CORP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$20,068
-44.3%
22,6500.0%0.00%
Q3 2022$36,000
-20.0%
22,6500.0%0.00%
Q2 2022$45,000
-54.5%
22,650
+74.2%
0.00%
Q3 2021$99,000
-72.1%
13,001
-64.6%
0.00%
-100.0%
Q2 2021$355,000
+34.0%
36,701
+14.3%
0.00%
Q1 2021$265,000
+4.7%
32,101
-13.2%
0.00%
Q4 2020$253,000
-44.9%
36,996
-10.1%
0.00%
-100.0%
Q3 2020$459,000
+44.8%
41,146
-18.4%
0.00%0.0%
Q2 2020$317,00050,4210.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders